Results 161 to 170 of about 78,778 (305)
CD38 inhibition increases neuronal survival and reduces α-synuclein <i>in vitro</i>, elevates brain NAD<sup>+</sup>, and reduces motor deficits in a Parkinson's disease model. [PDF]
Harvey JRM +16 more
europepmc +1 more source
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly diagnosed non‐transplant eligible multiple myeloma in Germany.
Eyck von der Heyde +9 more
wiley +1 more source
ABSTRACT Objectives B‐cell maturation antigen (BCMA)‐targeted therapies have recently transformed the management of relapsed or refractory multiple myeloma (RRMM). This study aimed to evaluate their implementation and real‐world impact within EMMY, a French longitudinal cohort. Methods Patients initiating a fourth or later line of therapy (L4+) between
Titouan Cazaubiel +24 more
wiley +1 more source
CD39, CD73, and CD38 track tumor burden and reveal immune remodeling during mogamulizumab therapy in Sézary syndrome. [PDF]
Marchisio S +13 more
europepmc +1 more source
Modulation of CD38 expression in human longevity: A flow cytometric study
The dynamics of CD38 expression innewborns and young healthy donors hasbeen widely investigated for many years.However, little is known about the modulationof this marker during humanageing.
TROIANO, Leonarda +8 more
core
CD38 enzymatic activity regulates LT-HSC exit from quiescence.
(A) Single CD38- and CD38+ LT-HSCs were sorted and cultured in liquid media with or without 78c, a CD38 inhibitor. (B) Frequency of LT-HSCs that had completed the first division during incubation time is presented (3 independent experiments).
Anupam Sinha (1974100) +19 more
core +1 more source
T‐Cell Response After SARS‐CoV‐2 Vaccination in Patients With Hematological Malignancy
ABSTRACT Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet vaccine‐induced T‐cell responses remain incompletely characterized.
L. S. Boerenkamp +7 more
wiley +1 more source
Cutaneous involvement by myeloid leukaemias: challenging cases with important implications
Myeloid leukaemias and precursors involving the skin are often challenging to diagnose with varied and overlapping clinical and histopathologic features. Nonetheless, they are critical for pathologists to recognize and accurately classify. This review discusses the clinical, histopathological and genetic features of myelodysplasia cutis (A) and ...
Alexandra C. Hristov
wiley +1 more source
NAD+ as a metabolic immune checkpoint in cancer. [PDF]
Izadpanah R, Alt EU.
europepmc +1 more source
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung +7 more
wiley +1 more source

